期刊文献+

环磷酰胺诱导嵌合形成和免疫耐受产生的实验研究 被引量:2

Chimerism and immune tolerance induced by cyclophsmide: an experimental study
下载PDF
导出
摘要 目的:通过环磷酰胺诱导大鼠嵌合及免疫耐受的产生,并初步探讨其安全性和可行性。方法:将Lewis大鼠随机分为三组。A组于实验前一天腹腔注射150mg/kg环磷酰胺,第1天经尾静脉输注2×108个供鼠骨髓细胞;B组于实验前一天腹腔注射等渗盐水2mL,第1天经尾静脉输注2×108个供鼠骨髓细胞;C组于实验前一天腹腔注射150mg/kg环磷酰胺,第1天经尾静脉注射等渗盐水2mL。观察各组大鼠移植物抗宿主病(GVHD)的发生。于输注骨髓细胞后第14天及移植皮肤出现排斥反应时,取外周血检查供鼠来源T细胞占总T细胞的比例。于第15天取供鼠腹部皮肤,进行皮肤移植,观察各组移植物存活时间。结果:A组可观察到明显的GVHD,第14天和移植皮肤被排斥时,供鼠来源T细胞占总T细胞的比率分别为25.49%和0.06%。A组移植皮肤存活时间为29.3d,显著长于B组(8.7d)和C组(8.4d)。结论:环磷酰胺可诱导嵌合免疫耐受的产生,在嵌合状态下可检测到供鼠来源的T细胞。当移植皮肤被排斥时,供鼠来源T细胞占总T细胞的比例显著降低。 Objective: The study was designed to induce chimerism and immune tolerance by Cyclophsmide and the safety was evatuated. Methods: Lewis rats were divided into three groups. Group A received 150 mg/kg Cyclophsmide by intraperritoneal injection( i. p. ) on day^-1 and 2 ×10^8 bone marrow cells from BN rats was transfused through tail vein on day 0. Group B received 2ml NS i. p. on day^-1 and then 2 ×10^8 bone marrow cells from BN rats through vein tail on day 0. Group C received 150mg/kg Cyclophsmide i.p. on d^-1 and then 2ml normal sodium(NS) through tail vein on d0. The symptom of graftversus-host disease (GVHD) was assessed. On day 14 and the day when grafted skin was rejected, chimerism was detected by flow cytometery. On day 15 all rats of the groups received skins from BN rats and the survival time of grafted skin was observed. Results : GVHD was observed in Group A and two rats of this group died. Chimerism was observed in Group A but not in Group B and C. Survival time of grafted skin in Group A was significantly longer than in Group B and Group C. Conclusion: Chimerism and immune tolerance can be induced by Cyclophosphmide and when the grafted skin was rejected, the ratio of T cells from BN significantly decreased.
出处 《肠外与肠内营养》 CAS 2007年第2期83-86,90,共5页 Parenteral & Enteral Nutrition
基金 江苏省自然科学基金(BK2004426)
关键词 免疫耐受 嵌合 移植物抗宿主病 Immune tolerance Chimerism GVHD
  • 相关文献

参考文献10

  • 1Colson YL,Zadach K,Nalesnik M,et al.Mixed allogeneic chimerism in the rat.Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts[J].Transplantation,1995,60(9):971-980. 被引量:1
  • 2Starzl TE,Demetris AJ,Murase N,et al.Cell migration,chimerism,and graft acceptance[J].Lancet,1992,339(8809):1579-1582. 被引量:1
  • 3黄世杰.vardenafil[J].国外医学(药学分册),2003,30(2):124-125. 被引量:114
  • 4Kurtz J,Ito H,Wekerle T,et al.Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT:lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells[J].Am J Transplant,2001,1(4):339-349. 被引量:1
  • 5Wekerle T,Sayegh MH,Hill J,et al.Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance[J].J Exp Med,1998,187(12):2037-2044. 被引量:1
  • 6Okayama J,Ko S,Kanehiro H,et al.Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide[J].J Surg Res,2004,120(1):102-110. 被引量:1
  • 7Blaha P,Bigenzahn S,Koporc Z,et al.Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning[J].Transplantation,2005,80(2):237-243. 被引量:1
  • 8Guo L,Fujino M,Kimura H,et al.AdCTLA-4Ig combined with donor splenocytes,bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model[J].Transpl Int,2004,17(1):15-21. 被引量:1
  • 9Li S,Thanikachalam M,Pang M,et al.Combined host-conditioning with CTLA4-Ig,tacrolimus,anti-lymphocyte serum,and low-dose radiation leads to stable mixed hematopoietic chimerism[J].Experimental Hematology,2001,29:534-541. 被引量:1
  • 10Trivedi HL,Vanikar AV,Modi PR,et al.Allogeneic hematopoietic stem-cell transplantation,mixed chimerism,and tolerance in living related donor renal allograft recipients[J].Transplant Proc,2005,37(2):737-742. 被引量:1

共引文献113

同被引文献23

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部